nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 ; Mus musculus

4 Article(s)
Pub. Year
#Total Relationships
1 34473771 Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells. 2021 1
2 22806547 Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice. 2013 Jan 1
3 23219147 Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in mice. 2013 Feb 4
4 23830367 Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation. 2013 Sep 3